New cancer clinical trial: Combination of Chemoradiation With Immunotherapy in Inoperable œsophageal Cancer

Published on: February 19, 2018 at 12:00PM
Condition:   Inoperable œsophageal Cancer
Interventions:   Drug: Nivolumab;   Drug: Ipilimumab;   Other: Chemoradiation
Sponsor:   European Organisation for Research and Treatment of Cancer - EORTC
Not yet recruiting
http://ift.tt/2HwmljE